| P2093 | author name string | Idriss M Bennani-Baiti | |
| | Nabila Bennani-Baiti | |
| P2860 | cites work | Cancer genome landscapes | Q22242276 |
| | Epigenetic differences arise during the lifetime of monozygotic twins | Q24531005 |
| | Core signaling pathways in human pancreatic cancers revealed by global genomic analyses | Q24606006 |
| | Mutational heterogeneity in cancer and the search for new cancer-associated genes | Q24606956 |
| | Characterizing the cancer genome in lung adenocarcinoma | Q24649926 |
| | Breast cancer intra-tumor heterogeneity | Q27000086 |
| | Cancer statistics, 2015 | Q27860576 |
| | Cancer genes and the pathways they control | Q28275089 |
| | Genetic heterogeneity in human disease | Q28280100 |
| | Intercohort gene expression co-analysis reveals chemokine receptors as prognostic indicators in Ewing's sarcoma | Q28284358 |
| | Intra-tumor genetic heterogeneity and mortality in head and neck cancer: analysis of data from the Cancer Genome Atlas | Q28650140 |
| | Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma | Q29615604 |
| | Subclass mapping: identifying common subtypes in independent disease data sets | Q31137364 |
| | The role of genetic diversity in cancer | Q33604953 |
| | Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline | Q33817285 |
| | Mesenchymal stem cell features of Ewing tumors | Q34003979 |
| | Gene symbol precision | Q34054463 |
| | Laser microdissection and two-dimensional difference gel electrophoresis reveal proteomic intra-tumor heterogeneity in colorectal cancer | Q34487770 |
| | Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity | Q34550775 |
| | EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation | Q34963463 |
| | Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer | Q35554809 |
| | Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification | Q35633666 |
| | Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response | Q35779256 |
| | Inflammation Modulates RLIP76/RALBP1 Electrophile-Glutathione Conjugate Transporter and Housekeeping Genes in Human Blood-Brain Barrier Endothelial Cells. | Q35787969 |
| | Subclonal diversification of primary breast cancer revealed by multiregion sequencing | Q35847434 |
| | Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma | Q36547263 |
| | Genomic and transcriptomic plasticity in treatment-naive ovarian cancer | Q37550198 |
| | Epigenetic and epigenomic mechanisms shape sarcoma and other mesenchymal tumor pathogenesis | Q37962606 |
| | Intratumor heterogeneity and chemotherapy-induced changes in EGFR status in non-small cell lung cancer | Q37963231 |
| | Differential protein expression and oncogenic gene network link tyrosine kinase ephrin B4 receptor to aggressive gastric and gastroesophageal junction cancers | Q38831868 |
| | miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy | Q39465507 |
| | Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy | Q40009768 |
| | DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets | Q40490707 |
| | Bone cancer incidence by morphological subtype: a global assessment | Q40857727 |
| | Integration of ERα-PELP1-HER2 signaling by LSD1 (KDM1A/AOF2) offers combinatorial therapeutic opportunities to circumventing hormone resistance in breast cancer | Q42669881 |
| | The frequency distribution of the product-moment correlation coefficient in random samples of any size drawn from non-normal universes | Q47447487 |
| | Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma. | Q50790389 |
| | Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma. | Q50791495 |
| | Inter- and intra-tumor profiling of multi-regional colon cancer and metastasis. | Q51014419 |
| | Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. | Q53201476 |
| | Heterogeneity of PTEN and ERG expression in prostate cancer on core needle biopsies: implications for cancer risk stratification and biomarker sampling. | Q53600979 |
| | Assessment of changes in tumor heterogeneity following neoadjuvant chemotherapy in primary esophageal cancer. | Q53633357 |
| | Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types. | Q54310538 |
| | Global gene expression in Ha-ras and B-raf mutated mouse liver tumors | Q80360153 |
| | H-Ras mutation modulates the expression of major cell cycle regulatory proteins and disease prognosis in oral carcinoma | Q80982194 |
| | Peripheral T-cell lymphoma | Q83865733 |
| | Value of positron emission tomography in diagnosing subcutaneous panniculitis-like T-cell lymphoma | Q86760181 |
| | C1013G/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma | Q87635685 |
| | Renal cell carcinoma metastasis to the thyroid: how long is long enough? | Q87648249 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bioinformatics | Q128570 |
| P304 | page(s) | 131-9 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Cancer Informatics | Q5031410 |
| P1476 | title | Cancer Bioinformatic Methods to Infer Meaningful Data From Small-Size Cohorts | |
| P478 | volume | 14 | |